Edgemont Pharmaceuticals Overview

  • Founded
  • 2006
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 4

Edgemont Pharmaceuticals General Information

Description

Developer of novel drugs intended for the treatment of psychiatric disorders. The company's novel drug formulations and therapies in the field of neuroscience helps in the treatment of major depressive disorder, bulimia nervosa, obsessive-compulsive disorder and panic disorder, enabling the neurological patients to resist their depression and anxiety problems.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Acquirer
Primary Office
  • 1250 Capital of Texas
  • Highway South, Building 3, Suite 400
  • Austin, TX 78746
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Edgemont Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Edgemont Pharmaceuticals‘s full profile, request access.

Request a free trial

Edgemont Pharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
Douglas Saltel Founder, President, Chairman & Chief Executive Officer
Randi Roberts Chief Commercial Officer
David Lowrance Chief Financial Officer & Treasurer
To view Edgemont Pharmaceuticals’s complete executive team members history, request access »

Edgemont Pharmaceuticals Board Members (8)

Name Representing Role Since
0000000 000000 Edgemont Pharmaceuticals Board Member 000 0000
0000000 000000 Edgemont Pharmaceuticals Founder, President, Chairman & Chief Executive Officer 000 0000
000000 000 Vatera Healthcare Partners Board Member 000 0000
000000 0000000 Self Board Member 000 0000
000000 000000000 Vatera Healthcare Partners Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Edgemont Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Edgemont Pharmaceuticals‘s full profile, request access.

Request a free trial